$PRPO
Precipio, Inc. Stock $prpo

$prpo Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000104396117000009 Filed on May 18, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$316.0K	$658.0K	$236.0K
YoY Change	-48.62%	178.81%	-68.53%
Cost Of Revenue	$284.0K	$459.0K	$505.0K
YoY Change	17.84%	-9.11%	8.6%
Gross Profit	-$24.00K	$199.0K	-$269.0K
YoY Change	-109.13%	-173.98%	-194.39%
Gross Profit Margin	-7.59%	30.24%	-113.98%
Selling, General & Admin		$1.620M	$1.704M
YoY Change		-4.93%	-5.54%
% of Gross Profit		814.07%
Research & Development		$134.0K	$270.0K
YoY Change		-50.37%	-40.13%
% of Gross Profit		67.34%
Depreciation & Amortization	$100.0K	$48.00K	$83.00K
YoY Change	0.0%	-42.17%	102.44%
% of Gross Profit		24.12%
Operating Expenses	$777.0K	$1.754M	$1.974M
YoY Change	41.79%	-11.14%	-12.46%
Operating Profit	-$801.0K	-$1.555M	-$2.243M
YoY Change	181.05%	-30.67%	13.86%
Interest Expense	-$220.0K	-$160.0K	-$80.00K
YoY Change	37.5%	100.0%	-76.47%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$0.00
YoY Change			-100.0%
Pretax Income	-$3.680M	-$1.835M	-$2.091M
YoY Change	728.83%	-12.24%	-9.79%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.680M	-$1.762M	-$3.264M
YoY Change	728.83%	-46.02%	7.33%
Net Earnings / Revenue	-1164.56%	-267.78%	-1383.05%
Basic Earnings Per Share
Diluted Earnings Per Share	-$92.00M	-$19.00M	-$10.33M
COMMON SHARES
Basic Shares Outstanding	26.86M shares	26.87M shares	20.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$970.0K	$60.00K	$220.0K
YoY Change	130.95%	-72.73%	-95.91%
Cash & Equivalents	$967.0K	$59.00K	$222.0K
Short-Term Investments
Other Short-Term Assets	$154.0K	$190.0K	$503.0K
YoY Change	-52.62%	-62.23%	-66.99%
Inventory	$108.0K	$15.00K	$44.00K
Prepaid Expenses	$100.0K	$100.0K	$200.0K
Receivables	$569.0K	$279.0K	$170.0K
Other Receivables	$100.0K	$100.0K	$100.0K
Total Short-Term Assets	$1.798M	$567.0K	$2.121M
YoY Change	-0.28%	-73.27%	-88.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$262.0K	$127.0K	$237.0K
YoY Change	28.43%	-46.41%	-81.7%
Goodwill	$13.83M
YoY Change
Intangibles	$21.10M	$531.0K	$1.146M
YoY Change	1950.53%	-53.66%	-85.41%
Long-Term Investments
YoY Change
Other Assets	$18.00K	$4.000K	$88.00K
YoY Change	-68.97%	-95.45%	-54.17%
Total Long-Term Assets	$35.21M	$662.0K	$1.471M
YoY Change	2627.5%	-55.0%	-90.95%
TOTAL ASSETS
Total Short-Term Assets	$1.798M	$567.0K	$2.121M
Total Long-Term Assets	$35.21M	$662.0K	$1.471M
Total Assets	$37.01M	$1.229M	$3.592M
YoY Change	1096.19%	-65.79%	-89.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.33M	$8.509M	$5.010M
YoY Change	83.77%	69.84%	0.04%
Accrued Expenses	$3.521M	$3.398M	$3.339M
YoY Change	23.67%	1.77%	41.01%
Deferred Revenue
YoY Change
Short-Term Debt	$170.0K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$513.0K	$7.368M	$7.346M
YoY Change	-93.43%	0.3%	1304.59%
Total Short-Term Liabilities	$16.31M	$21.13M	$17.28M
YoY Change	-7.93%	22.27%	56.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$171.0K	$128.0K	$255.0K
YoY Change	-23.32%	-49.8%	-85.03%
Total Long-Term Liabilities	$171.0K	$128.0K	$255.0K
YoY Change	-23.32%	-49.8%	-97.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.31M	$21.13M	$17.28M
Total Long-Term Liabilities	$171.0K	$128.0K	$255.0K
Total Liabilities	$17.24M	$21.87M	$19.00M
YoY Change	-11.06%	15.1%	-22.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.29M	-$227.3M	-$216.7M
YoY Change	-92.98%	4.89%	15.89%
Common Stock	$64.00K	$268.0K	$207.0K
YoY Change	-72.29%	29.47%	73.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.77M	-$20.64M	-$15.41M
YoY Change
Total Liabilities & Shareholders Equity	$37.01M	$1.229M	$3.592M
YoY Change	1096.19%	-65.79%	-89.59%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$3.680M	-$1.762M	-$3.264M
YoY Change	728.83%	-46.02%	7.33%
Depreciation, Depletion And Amortization	$100.0K	$48.00K	$83.00K
YoY Change	0.0%	-42.17%	102.44%
Cash From Operating Activities	-$850.0K	-$50.00K	-$1.924M
YoY Change	-155.56%	-97.4%	-45.23%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$19.00K
YoY Change		-100.0%	90.0%
Acquisitions
YoY Change
Other Investing Activities	$100.0K	$0.00	$7.000K
YoY Change	900.0%	-100.0%	-170.0%
Cash From Investing Activities	$100.0K	$0.00	-$26.00K
YoY Change	233.33%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.710M	-$1.000K	$1.728M
YoY Change	-223.91%	-100.06%	-76.31%
NET CHANGE
Cash From Operating Activities	-850.0K	-$50.00K	-$1.924M
Cash From Investing Activities	100.0K	$0.00	-$26.00K
Cash From Financing Activities	1.710M	-$1.000K	$1.728M
Net Change In Cash	960.0K	-$51.00K	-$222.0K
YoY Change	433.33%	-77.03%	-105.87%
FREE CASH FLOW
Cash From Operating Activities	-$850.0K	-$50.00K	-$1.924M
Capital Expenditures		$0.00	$19.00K
Free Cash Flow		-$50.00K	-$1.943M
YoY Change		-97.43%	-44.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	TRANSGENOMIC INC
CY2017Q1	tbio	Class Of Warrant Or Right Number Of Issued Warrants Or Rights ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights	2933106	shares
CY2017Q1	tbio	Classof Warrantor Right Numberof Issued Warrants Expired ClassofWarrantorRightNumberofIssuedWarrantsExpired	3362276	shares
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001043961
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26863062	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2017Q1	tbio	Delinquent Accounts Payable DelinquentAccountsPayable	600000	USD
CY2016Q1	tbio	Gain Loss On Stock Warrants Revaluation GainLossOnStockWarrantsRevaluation	321000	USD
CY2017Q1	tbio	Gain Loss On Stock Warrants Revaluation GainLossOnStockWarrantsRevaluation	-33000	USD
CY2016Q1	tbio	Initial Fair Valueof Warrants Issued InitialFairValueofWarrantsIssued	1800000	USD
CY2016Q1	tbio	Initial Fair Valueof Warrants Issued InitialFairValueofWarrantsIssued	1827000	USD
CY2017Q1	tbio	Initial Fair Valueof Warrants Issued InitialFairValueofWarrantsIssued	0	USD
CY2016Q1	tbio	Interest Income And Expense Net InterestIncomeAndExpenseNet	-169000	USD
CY2017Q1	tbio	Interest Income And Expense Net InterestIncomeAndExpenseNet	-247000	USD
CY2016Q1	tbio	Other Income Expense OtherIncomeExpense	152000	USD
CY2017Q1	tbio	Other Income Expense OtherIncomeExpense	-280000	USD
CY2010Q4	tbio	Proceedsfromissuanceofcommonstockandconvertiblenotes Proceedsfromissuanceofcommonstockandconvertiblenotes	6000000	USD
CY2017Q1	tbio	Working Capital Deficiency WorkingCapitalDeficiency	-20600000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6541000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	8509000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	225000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	279000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3546000	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3398000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	205877000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	206342000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12970881	shares
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4425218	shares
CY2016Q4	us-gaap	Assets Assets	1259000	USD
CY2017Q1	us-gaap	Assets Assets	1229000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	495000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	567000	USD
CY2016Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	31000	USD
CY2017Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	24000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	444000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	222000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-222000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-51000	USD
CY2016Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-612000	USD
CY2017Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	80000	USD
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3334011	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26446927	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26863062	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26446927	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26863062	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	264000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	268000	USD
CY2016Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	199000	USD
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	200000	USD
CY2017Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2016Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	505000	USD
CY2017Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	459000	USD
CY2016Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	7814000	USD
CY2017Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	7368000	USD
CY2016Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2017Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	499000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	170000	USD
CY2017Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	133000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	100000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	100000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	83000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	224000	USD
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	192000	USD
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	100000	USD
CY2016Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-321000	USD
CY2017Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	33000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	100000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	100000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	100000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	100000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	100000	USD
CY2016Q1	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2017Q1	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-358000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	-269000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	199000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2091000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1835000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2091000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1835000	USD
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1173000	USD
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	73000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1230000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1967000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-73000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	55000	USD
CY2016Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	17000	USD
CY2017Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-481000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-587000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-41000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	45000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	562000	USD
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	531000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	0	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	0	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	24000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	15000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	20609000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	21872000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1259000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1229000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19824000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21129000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7814000	USD
CY2017Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	7368000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2017Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1728000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1924000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1312000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-130000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-3264000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-1762000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3657000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1762000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2017Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	1974000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	1754000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2243000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1555000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	105000	USD
CY2017Q1	us-gaap	Other Assets Current OtherAssetsCurrent	200000	USD
CY2017Q1	us-gaap	Other Assets Current OtherAssetsCurrent	190000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	58000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1529000	USD
CY2017Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1529000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	203000	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	128000	USD
CY2017Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	100000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2016Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	219000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2016Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	393000	USD
CY2017Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	214705	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	214705	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	214705	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	214705	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	2000	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	2000	USD
CY2017Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	100000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1779000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2016Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500000	USD
CY2017Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	127000	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1000	USD
CY2016Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	550000	USD
CY2017Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	270000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	134000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-225493000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-227255000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	236000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	658000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1704000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1620000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	110000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-24000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y0M0D
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2016Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	89000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-19350000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	-20643000	USD
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	582000	USD
CY2017Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	615000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20323333	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26779835	shares

Files In Submission

Name	View Source	Status
0001043961-17-000009-index-headers.html	Edgar Link	pending
0001043961-17-000009-index.html	Edgar Link	pending
0001043961-17-000009.txt	Edgar Link	pending
0001043961-17-000009-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tbio-20170331.xml	Edgar Link	completed
tbio-20170331.xsd	Edgar Link	pending
tbio-20170331x10q.htm	Edgar Link	pending
tbio-20170331_cal.xml	Edgar Link	unprocessable
tbio-20170331_def.xml	Edgar Link	unprocessable
tbio-20170331_lab.xml	Edgar Link	unprocessable
tbio-20170331_pre.xml	Edgar Link	unprocessable
tbio-ex311_20170331x10q.htm	Edgar Link	pending
tbio-ex321_20170331x10q.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRPO
Precipio, Inc. Stock $prpo

2017 Q2 Form 10-Q Financial Statement

#000104396117000009 Filed on May 18, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRPO Precipio, Inc. Stock $prpo

2017 Q2 Form 10-Q Financial Statement

#000104396117000009 Filed on May 18, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRPO
Precipio, Inc. Stock $prpo